Medicenna Therapeutics Corp. SEC filings MDNAF
Medicenna Therapeutics Corp. has 178 filings in SEC EDGAR's recent list, going back to Mar 30, 2020. Its latest annual report, Form 20-F, was filed on Jun 27, 2023 for the period ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on May 13, 2024. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jun 27, 2023 | Mar 31, 2023 |
| 20-F | Annual report (foreign issuer) | Jun 22, 2022 | Mar 31, 2022 |
| 40-F | Annual report (Canadian issuer) | May 28, 2021 | Mar 31, 2021 |
Showing 3 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDNAF (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1807983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.